Read on Twitter
Simulacra. https://www.drugs.com/newdrugs/fda-approves-cyltezo-adalimumab-adbm-biosimilar-humira-4583.html
Golden Handshakes Shower Down. https://au.finance.yahoo.com/news/abbvie-settles-humira-litigation-boehringer-114611831.html
All systems are corrupt.
We are all connected. https://www.tga.gov.au/apm-summary/idacio
Even in #Australia. https://www.centerforbiosimilars.com/view/fresenius-kabi-strikes-deal-with-abbvie-over-humira
Time to play HS B.I.N.G.O.
Rheumatoid Arthritis. Psoriatic Arthritis. Crohn's Disease, Acute. Crohn's Disease, Maintenance. Psoriasis. Juvenile Idiopathic Arthritis. Ulcerative Colitis. Hidradenitis Suppurativa. Uveitis.
Thoroughly insignificant and unimportant tweet'o'mine from Jan 10 2018.
4th Oct. #Australia via @TGAgovau
Database of Adverse Event Notifications for Adalimumab.
2506 reports/cases
2189 cases with a single suspected medicine:
41 cases where death was a reported outcome:
10 cases mentioning 'hidradenitis'.
http://bit.ly/2020_TGA_Au_Adalimumab
Database of Adverse Event Notifications for Adalimumab.
2506 reports/cases
2189 cases with a single suspected medicine:
41 cases where death was a reported outcome:
10 cases mentioning 'hidradenitis'.
http://bit.ly/2020_TGA_Au_Adalimumab
March 2017 | There must be 31 Reasons To Leave Your Sponsor. | Howes, RJ | Journal of Dead Social Media.
Brave, Courageous & Staunch is the HS patient or HS medical advocate who does NOT check this out. http://bit.ly/X_Reasons_To_Leave_Your_Sponsor
Brave, Courageous & Staunch is the HS patient or HS medical advocate who does NOT check this out. http://bit.ly/X_Reasons_To_Leave_Your_Sponsor
"I would also rationally choose and vow not to now or ever use a theoretical or proposed Australian Not For Profit HS advocacy organisation as a major platform for excessive and unreasonable corporate donor acknowledgement."
"If Donor acknowledgement once per year is not enough for your corporation than I apologise. I sincerely thank you for your interest in my disease. Please close the door on your way out." #Take_The_RjH_Pledge
"Disclosure of (potential) conicts (sic) of interest in tiny print for this New England Journal of Medicine Article, is 770 words long, with 5,529 characters."
"Hint to ( #medical) #Journal editors, the smaller you make
the print, the more interest I have in reading the content"
#Dermatology #Dermatologia
the print, the more interest I have in reading the content"
#Dermatology #Dermatologia
For those outside of the #UnitedStates it may be helpful in many unintended & unexpected ways to watch an #American ad for #adalimumab. https://bit.ly/30KIxlv
Last tweet in this thread I tried to find some balance, but all I did was supercharge my own confirmation bias.
October | Three more reasons to leave your sponsors. https://link.springer.com/article/10.1007/s40278-020-84257-0
Maybe this belongs in this thread, maybe not. This is a thread which is designed not be cogent or articulate in any way. It's a random thread in a random world expressed on random social media. https://pubmed.ncbi.nlm.nih.gov/31098898/
